Literature DB >> 23994059

The role of L-type calcium channels in the development and expression of behavioral sensitization to ethanol.

Julie Broadbent1.   

Abstract

Behavioral sensitization is thought to play a significant role in drug addiction. L-type calcium channels have been implicated in sensitization to stimulant and opiate drugs but it is unclear if these channels also contribute to sensitization to ethanol. The effects of three L-type calcium channel blockers, nifedipine (1-7.5 mg/kg), diltiazem (12.5-50 mg/kg), and verapamil (12.5 and 25 mg/kg), on sensitization to ethanol (2 g/kg) were examined in DBA/2J mice. All three blockers reduced but did not prevent expression of sensitization. Only nifedipine blocked acquisition of sensitization. Nifedipine and verapamil decreased blood ethanol levels. The current findings suggest L-type calcium channels do not play a substantial role in sensitization to ethanol and that the neural mechanisms underlying sensitization to ethanol are distinct from those mediating sensitization to stimulants and opiates.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol; Behavioral sensitization; Ethanol; L-type calcium channel blockers; Locomotor activity; Mice

Mesh:

Substances:

Year:  2013        PMID: 23994059      PMCID: PMC3811096          DOI: 10.1016/j.neulet.2013.08.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

1.  L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice.

Authors:  Qi Zhang; Jun-Xu Li; Ji-Wang Zheng; Rui-Ke Liu; Jian-Hui Liang
Journal:  Eur J Pharmacol       Date:  2003-04-25       Impact factor: 4.432

2.  Cilnidipine, an L/N-type calcium channel blocker prevents acquisition and expression of ethanol-induced locomotor sensitization in mice.

Authors:  Pravinkumar Bhutada; Yogita Mundhada; Jayshree Patil; Anand Rahigude; Krushna Zambare; Prashant Deshmukh; Dhanshree Tanwar; Kishor Jain
Journal:  Neurosci Lett       Date:  2012-03-03       Impact factor: 3.046

Review 3.  The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization.

Authors:  Stephanie C Licata; R Christopher Pierce
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

4.  Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule.

Authors:  D S Lorrain; G M Arnold; P Vezina
Journal:  Behav Brain Res       Date:  2000-01       Impact factor: 3.332

Review 5.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

6.  Calcium channel blockers and behavioral sensitization.

Authors:  R Karler; S A Turkanis; L M Partlow; L D Calder
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

7.  Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors:  P E Paulson; D M Camp; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Expression of behavioral sensitization to ethanol by DBA/2J mice: the role of NMDA and non-NMDA glutamate receptors.

Authors:  Julie Broadbent; Kathryn M Kampmueller; Sharon A Koonse
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

9.  Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists.

Authors:  W P Watson; H J Little
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

10.  Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization.

Authors:  J Broadbent; N J Grahame; C L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.